Abstract:Background: A significant proportion of young at-risk patients and nonsmokers are excluded by the current guidelines for lung cancer (LC) screening, resulting in low-screening adoption. The vision of the US National Academy of Medicine to transform health systems into learning health systems (LHS) holds promise for bringing necessary structural changes to health care, thereby addressing the exclusivity and adoption issues of LC screening. Objective: This study aims to realize the LHS vision by designing an equitable, machine learning (ML)-enabled LHS unit for LC screening. It focuses on developing an inclusive and practical LC risk prediction model, suitable for initializing the ML-enabled LHS (ML-LHS) unit. This model aims to empower primary physicians in a clinical research network, linking central hospitals and rural clinics, to routinely deliver risk-based screening for enhancing LC early detection in broader populations. Methods: We created a standardized data set of health factors from 1397 patients with LC and 1448 control patients, all aged 30 years and older, including both smokers and nonsmokers, from a hospital's electronic medical record system. Initially, a data-centric ML approach was used to create inclusive ML models for risk prediction from all available health factors. Subsequently, a quantitative distribution of LC health factors was used in feature engineering to refine the models into a more practical model with fewer variables. Results: The initial inclusive 250-variable XGBoost model for LC risk prediction achieved performance metrics of 0.86 recall, 0.90 precision, and 0.89 accuracy. Post feature refinement, a practical 29-variable XGBoost model was developed, displaying performance metrics of 0.80 recall, 0.82 precision, and 0.82 accuracy. This model met the criteria for initializing the ML-LHS unit for risk-based, inclusive LC screening within clinical research networks. Conclusions: This study designed an innovative ML-LHS unit for a clinical research network, aiming to sustainably provide inclusive LC screening to all at-risk populations. It developed an inclusive and practical XGBoost model from hospital electronic medical record data, capable of initializing such an ML-LHS unit for community and rural clinics. The anticipated deployment of this ML-LHS unit is expected to significantly improve LC-screening rates and early detection among broader populations, including those typically overlooked by existing screening guidelines.

Development and External Validation of a Machine Learning Model to Predict Restriction from Spirometry

A Normal Forced Vital Capacity Does Not Reliably or Equitably Exclude Restriction

Development of machine learning model to predict pulmonary function with low‐dose CT‐derived parameter response mapping in a community‐based chest screening cohort

Machine learning for screening of at-risk, mild and moderate COPD patients at risk of FEV1 decline: results from COPDGene and SPIROMICS

Artificial Intelligence Applied to Forced Spirometry in Primary Care

Implementation of prognostic machine learning algorithms in paediatric chronic respiratory conditions: a scoping review

Debunking the GAMLSS myth: Simplicity reigns in pulmonary function diagnostics

BeyondCT: A deep learning model for predicting pulmonary function from chest CT scans

Racial Differences in Accuracy of Predictive Models for High-Flow Nasal Cannula Failure in COVID-19

Massive external validation of a machine learning algorithm to predict pulmonary embolism in hospitalized patients

Lung volumes and airway resistance in patients with a possible restrictive pattern on spirometry

Race-Specific Spirometry Equations Do Not Improve Models of Dyspnea and Quantitative Chest CT Phenotypes

Development and evaluation of a computerized algorithm for the interpretation of pulmonary function tests

External validation of machine learning prediction model for pulmonary hypertension due to left heart disease

Development of Lung Cancer Risk Prediction Machine Learning Models for Equitable Learning Health System: Retrospective Study

Establishment and validation of multiclassification prediction models for pulmonary nodules based on machine learning

Race-Neutral Equations and Pulmonary Function Test Interpretation in Two Pediatric Cohorts

A Machine Learning Application to Predict Early Lung Involvement in Scleroderma: A Feasibility Evaluation

Novel Artificial Intelligence-Based Technology to Diagnose Asthma Using Methacholine Challenge Tests

Machine Learning and Real-World Data to Predict Lung Cancer Risk in Routine Care

Development and validation of a prediction model for airflow obstruction in older Chinese: Guangzhou Biobank Cohort Study